SAN ANTONIO - bioAffinity Technologies, Inc. (NASDAQ:BIAF) announced a study with Brooke Army Medical Center to validate its CyPath Lung diagnostic test using sputum samples collected through tracheal ...
CyPath® Lung test supported recommendation for surveillance strategy, rather than subjecting elderly patient to an invasive, risky and costly biopsy procedure Despite a suspicious nodule during a ...
bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a new clinical case study in ...
DRAMINSKI FAST was designed for basic ultrasound diagnostics. It can be used even in the most difficult site and weather conditions. It was made for field and military medicine, emergency medicine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results